Scott Gottlieb to return to American Enterprise Institute to focus on drug pricing

Gottlieb, who announced his resignation last month after 23 months as FDA commissioner, told The Washington Post he would focus on drug pricing and “market failures” that lead to high costs.

More From BioPortfolio on "Scott Gottlieb to return to American Enterprise Institute to focus on drug pricing"